Palo Capital’s Amedisys AMED Stock Holding History

Palo Capital’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,931	Closed	-$238K	–	211
2016 Q1	$238K	Buy	+4,931	New	+$190K	0.19%	117

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Palo Capital's AMED Position: Q2 2016 in Review

Palo Capital sold out of Amedisys (AMED) in Q2 2016, closing a stake of 4,931 shares — an estimated $238K sold.

Palo Capital first reported a position in AMED in Q1 2016 and held it in 1 quarter. The position peaked at $238K in Q1 2016. 168 funds tracked by Wall St. Rank hold AMED as of Q2 2016.

Palo Capital reported no remaining Amedisys position as of Q2 2016 after selling out during the quarter.
Palo Capital sold 4,931 Amedisys shares in Q2 2016, an estimated $238K.
Palo Capital first reported a position in Amedisys in Q1 2016 and held it in 1 quarter.
Palo Capital's Amedisys position peaked at $238K in Q1 2016.
168 funds tracked by Wall St. Rank held Amedisys as of Q2 2016.

Based on Palo Capital's 13F filing for Q2 2016, filed 20 Jul 2016.